VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 106 participants.
Also called NCT03686306
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT03686306 -
2020-000231-42
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03686306. Randomized; triple masking; primary purpose treatment. Start 2021-11-24 (actual); primary completion 2025-11-24 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.
- Acronym
- VIRTUOSE
- Condition
- Peripheral Artery Disease
- Intervention (Drug)
- Sildenafil
- Intervention (Drug)
- Placebo
- Lead sponsor
- Rennes University Hospital
Record details
- Record id
cardio:ct-nct03686306- Content hash
57f90c75b9e607c125358aa87efb4d7bb44378bf381589b4c99ca0456dd2689b